Skip to content

RealTime 08L21-002

by Abbott Molecular

RealTime 08L21-002 is a Class II device made by Abbott Molecular, approved under FDA PMA P120012 on 20 Jun 2013 and listed in FDA GUDID since 1 Sep 2016 (UDI-DI 00884999042513), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

PMA P120012

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00884999042513 UDI-DI Date1 Sep 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA PMAAPRL from GUDID NumberP120012 Date20 Jun 2013DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA PMA P120012 decided 20 Jun 2013 Active
  • FDA GUDID UDI-DI 00884999042513 listed 1 Sep 2016 Listed

Timeline

2 dated events

  1. Approved FDA PMA P120012
  2. Listed FDA GUDID 00884999042513

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

GUDID

Trade name
RealTime
Generic name
Laboratory instrument/analyser application software IVD
Model / Ref / Catalog
08L21-002
Primary DI / UDI-DI
00884999042513
PMA number
FDA product code
OBF
GMDN term
Laboratory instrument/analyser application software IVD
Device class
Class II
Regulation number
866.3170
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Laboratory instrument/analyser application software IVD.

Other devices from Abbott Molecular

See all devices from Abbott Molecular →

Properties

  • Convenience kit
  • Lot / batch number
Other properties (13, all answered No)